3,5-Dibenzyloxy terbutaline, identified by its CAS number 28924-25-6, is a synthetic compound that belongs to the class of beta-adrenergic agonists. It is characterized by the presence of two benzyloxy groups attached to the 3 and 5 positions of the terbutaline structure, which is a derivative of the naturally occurring catecholamines. This modification enhances its pharmacological properties, particularly in terms of selectivity and potency. The compound is typically used in research settings to study its effects on bronchial dilation and its potential therapeutic applications in treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its chemical structure contributes to its ability to activate beta-2 adrenergic receptors, leading to smooth muscle relaxation in the airways. Additionally, the presence of the benzyloxy groups may influence its solubility, stability, and metabolic profile. As with many beta-agonists, careful consideration of dosage and potential side effects is essential in any therapeutic context.

3,5-Dibenzyloxy terbutalline

28924-25-6: 3,5-Dibenzyloxy terbutaline, identified by its CAS number 28924-25-6, is a synthetic compound that belongs to the class of beta-adrenergic agonists. It is characterized by the presence of two benzyloxy groups attached to the 3 and 5 positions of the terbutaline structure, which is a derivative of the naturally occurring catecholamines. This modification enhances its pharmacological properties, particularly in terms of selectivity and potency. The compound is typically used in research settings to study its effects on bronchial dilation and its potential therapeutic applications in treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its chemical structure contributes to its ability to activate beta-2 adrenergic receptors, leading to smooth muscle relaxation in the airways. Additionally, the presence of the benzyloxy groups may influence its solubility, stability, and metabolic profile. As with many beta-agonists, careful consideration of dosage and potential side effects is essential in any therapeutic context.

CAS 28924-25-6

3,5-Dibenzyloxy terbutalline

Benzenemethanol, α-[[(1,1-dimethylethyl)amino]methyl]-3,5-bis(phenylmethoxy)-

Ref: IN-DA002X3W

Terbutaline Impurity 4

Ref: 4Z-T-4910

Terbutaline 3,5-Dibenzyl Ether

Ref: ST-EA-CP-T42012